- Anti-hepatic steatosis, anti-hepatic apoptosis (↓serum ALT, AST, TG, TC) in HFD-mice (200, 400 mg/kg bw, p.o., 8 weeks). - Reduced lipid accumulation, apoptosis, ROS level in FFA-induced HepG2 cells (20–80 ug/ml, 24 h). This evidence concerns the gene GPT and Hepatic steatosis.